Back to search
Growth Alteration
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Growth Alteration trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Growth Alteration trials you may qualify forThis is a single-arm, open-label, multicenter, investigator-initiated Phase 2 trial to evaluate the efficacy and safety of E7090 in patients with advanced or re…
The goal of this observational study is to learn about how the blood leucocytes from patients with and without exposure or disease from tuberculosis (TB) are ab…
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of KIN-2787 in adults with BRAF/NRAS-mutated…
This phase II trial studies the effect of rogaratinib in treating patients with sarcoma with a change in a group of proteins called fibroblast growth factor rec…